Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

TOBRAMYCIN - ANVISA Registration 10287410827

Access comprehensive regulatory information for TOBRAMYCIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10287410827 and manufactured by ROCHE DIAGNOSTICS GMBH. The registration is held by ROCHE DIAGNร“STICA BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS HEALTHCARE DIAGNOSTICS INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10287410827
Registration Details
ANVISA Registration Number: 10287410827
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Tobramicina
Risk Class II

Registration Details

10287410827

25351294269200981

30280358000186

Company Information

Germany
PT: ALEMANHA

Dates and Status

Sep 10, 2009

VIGENTE

09/18/2025 19:00:01